Guizhou Sanli Pharmaceutical Co Ltd (603439) — Cash Flow Quality Index
Guizhou Sanli Pharmaceutical Co Ltd (603439) has a Cash Flow Quality Index of 0.78x as of June 2025. Operating cash flow of CN¥32.03 Million is below net income of CN¥41.11 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Guizhou Sanli Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guizhou Sanli Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Guizhou Sanli Pharmaceutical Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Guizhou Sanli Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Cash Flow Quality Index for Guizhou Sanli Pharmaceutical Co Ltd (2013–2024)
Year-by-year earnings quality comparison for Guizhou Sanli Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.38x | CN¥107.07 Million | CN¥279.84 Million | ▼ -59.5% |
| 2023 | 0.95x | CN¥276.70 Million | CN¥292.70 Million | ▼ -38.1% |
| 2022 | 1.53x | CN¥293.29 Million | CN¥191.94 Million | ▲ +46.5% |
| 2021 | 1.04x | CN¥155.04 Million | CN¥148.60 Million | ▲ +55.0% |
| 2020 | 0.67x | CN¥63.25 Million | CN¥93.95 Million | ▼ -22.9% |
| 2019 | 0.87x | CN¥116.24 Million | CN¥133.07 Million | ▲ +28.1% |
| 2018 | 0.68x | CN¥75.35 Million | CN¥110.48 Million | ▲ +4.0% |
| 2017 | 0.66x | CN¥57.47 Million | CN¥87.63 Million | ▲ +39.9% |
| 2016 | 0.47x | CN¥35.10 Million | CN¥74.88 Million | ▼ -25.9% |
| 2015 | 0.63x | CN¥33.28 Million | CN¥52.61 Million | ▲ +3154.9% |
| 2014 | 0.02x | CN¥563.46K | CN¥28.99 Million | ▼ -98.7% |
| 2013 | 1.55x | CN¥30.09 Million | CN¥19.37 Million | — |